The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

iShares U.S. Healthcare ETF

NYSE: IYH
Last

(U.S.) $149.32

Today's change+0.82 +0.55%
Updated December 19 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

iShares U.S. Healthcare ETF

NYSE: IYH
Last

(U.S.) $149.32

Today's change+0.82 +0.55%
Updated December 19 4:00 PM -5GMT. Delayed by at least 15 minutes.

iShares U.S. Healthcare ETF up (U.S.)$0.82

iShares U.S. Healthcare ETF closed up Friday by (U.S.)$0.82 or 0.55% to (U.S.)$149.32. Over the last five days, shares have gained 3.14% and 28.18% year to date. Shares have outperformed the S&P 500 by 15.59% during the last year.

Key company metrics

  • Open(U.S.) $148.65
  • Previous close(U.S.) $148.50
  • High(U.S.) $149.85
  • Low(U.S.) $147.92
  • Bid / Ask-- / --
  • YTD % change+28.18%
  • Volume221,430
  • Average volume (10-day)384,261
  • Average volume (1-month)342,307
  • Average volume (3-month)464,222
  • 52-week range(U.S.) $114.43 to (U.S.) $150.27
  • Beta0.71
  • Trailing P/E9.05×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.11
  • Dividend yield0.75%
  • Trailing EPS(U.S.) $16.50
Updated December 19 4:00 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 30, 201404/30/2014Oct 31, 201310/31/2013Apr 30, 201304/30/2013Oct 31, 201210/31/2012
Revenue181287
Total other revenue--------
Total revenue181287
Gross profit--------
Total cost of revenue--------
Total operating expense5321
Selling / general / administrative5321
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income13965
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax21914214746
Income after tax21914214746
Income tax, total0000
Net income21914214746
Total adjustments to net income--------
Net income before extra. items21914214746
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items21914214746
Inc. avail. to common incl. extra. items21914214746
Diluted net income21914214746
Dilution adjustment--------
Diluted weighted average shares2816128
Diluted EPS excluding extraordinary itemsvalue per share7.818.6912.715.58
Dividends per sharevalue per share0.660.640.680.69
Diluted normalized EPSvalue per share7.818.6912.715.58